Science Researcher Update: Spotlight on Meetings, Conferences, and Events

 

Conference - London, United Kingdom

 

SMi’s 10th Annual ADMET conference will provide essential insight into the latest novel technologies being used in the field of Predictive Toxicology and ADME/Tox. With drug induced liver and Cardiotoxicity still being major causes of drug attrition rates, the programme will feature case studies on development of human cellular models and state-of-the-art in vitro used to assess toxicity. This is a must attend event if you want to be at the forefront of pharmacokinetic/pharmacodynamic models; drug transporter assays in drug discovery; time-dependent inhibition screens in early drug discovery; the system-dependent inhibition of CYP enzymes and the integrating predictive toxicology framework.

Reasons why you should attend:

•In vitro models and technologies for detecting Cardiotoxicity
•Analyse performance of different in vitro models to detect human hepatotoxic drugs
•Human stem cell derived cardiomyocytes
•Regulatory DDI Guidance(s) for drug transporters – an overview review of current FDA, EMA and JMHLW (Japan) guidance for industry
•Mitigating errors in early human dose predictions and setting the criteria for ADME end points

 

If you'd like to ask a question or post a comment about this talk please do so below.